Cardiorenal protection with SGLT2: Lessons from the cardiovascular outcome trials
Author:
Affiliation:
1. Department of MedicineUniversity of Porto Porto Portugal
2. Department of Medicine, Division of CardiologyUT Health San Antonio San Antonio Texas
Publisher
Wiley
Subject
Endocrinology, Diabetes and Metabolism
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/1753-0407.13007
Reference99 articles.
1. Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology
2. The use of language in diabetes care and education;Dickinson JK;Diabetes Care,2017
3. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
4. Evaluation of Bone Mineral Density and Bone Biomarkers in Patients With Type 2 Diabetes Treated With Canagliflozin
5. Empagliflozin and Assessment of Lower-Limb Amputations in the EMPA-REG OUTCOME Trial
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Heart failure: pathophysiology and the emergence of novel therapies;Cardiovascular Endocrinology and Metabolism;2023
2. Predictors of cardio-kidney complications and treatment failure in patients with chronic kidney disease and type 2 diabetes treated with SGLT2 inhibitors;BMC Medicine;2022-01-10
3. Use of Sodium-Glucose Cotransporter-2 Inhibitors in Clinical Practice for Heart Failure Prevention and Treatment: Beyond Type 2 Diabetes. A Narrative Review;Advances in Therapy;2021-12-09
4. SGLT-2 inhibitors: A step forward in the treatment of heart failure with reduced ejection fraction;Revista Portuguesa de Cardiologia;2021-09
5. SGLT-2 inhibitors: A step forward in the treatment of heart failure with reduced ejection fraction;Revista Portuguesa de Cardiologia (English Edition);2021-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3